Erratum
for
Ascierto et al., J Clin Oncol 23 (30) 7660-7668.
Journal of Clinical Oncology, Vol 24, No 24 (August 20), 2006: pp. 4047
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.001
ERRATUM
The October 20, 2005, article by Ascierto et al entitled, "Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies" (J Clin Oncol 23:7660-7668, 2005) contained errors. In Figure 2, inaccurate data were reported. The corrected figure is reprinted below in its entirety.
View larger version (12K):
[in this window]
[in a new window]
|
Fig 2. Pharmacodynamics of ADI-SS PEG 20,000 mw in (A) US patients and (B) Italian patients with melanoma. The data shown represent the means ± SE for each of the cohorts. The limit of detection of arginine was less than 2 µmol/L.
|
|
In Figure 3, the legend should have read:
"Pharmacokinetics of ADI-SS PEG 20,000 mw in (A) and (C) US patients and (B) and (D) Italian patients with melanoma. The amount of arginine deiminase (ADI) enzyme activity in plasma (A) and (B) and the amount of ADI protein present (C) and (D) were determined. The data shown represent the means ± SE of each of the cohorts."
The online version has been corrected in departure from the print.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
